Since December 2019, COVID-19 has occurred unexpectedly and emerged as a health problem worldwide. Despite the rapidly increasing number of cases in subsequent weeks, the clinical characteristics of pediatric cases are rarely described. A cross-sectional multicenter study was carried out in 10 hospitals across Hubei province. A total of 25 confirmed pediatric cases of COVID-19 were collected. The demographic data, epidemiological history, underlying diseases, clinical manifestations, laboratory and radiological data, treatments, and outcomes were analyzed. Of 25 hospitalized patients with COVID-19, the boy to girl ratio was 1.27:1. The median age was 3 years. COVID-19 cases in children aged <3 years, 3.6 years, and ≥6-years patients were 10 (40%), 6 (24%), and 9 (36%), respectively. The most common symptoms at onset of illness were fever (13 [52%]), and dry cough (11 [44%]). Chest CT images showed essential normal in 8 cases (33.3%), unilateral involvement of lungs in 5 cases (20.8%), and bilateral involvement in 11 cases (45.8%). Clinical diagnoses included upper respiratory tract infection (n=8), mild pneumonia (n=15), and critical cases (n=2). Two critical cases (8%) were given invasive mechanical ventilation, corticosteroids, and immunoglobulin. The symptoms in 24 (96%) of 25 patients were alleviated and one patient had been discharged. It was concluded that children were susceptible to COVID-19 like adults, while the clinical presentations and outcomes were more favorable in children. However, children less than 3 years old accounted for majority cases and critical cases lied in this age group, which demanded extra attentions during home caring and hospitalization treatment.
Bogoch II, Watts A, Thomas-Bachli A, et al. Pneumonia of Unknown Etiology in Wuhan, China: Potential for International Spread Via Commercial Air Travel. J Travel Med, 2020.doi: https://doi.org/10.1093/jtm/taaa008.
Lu H, Stratton CW, Tang YW. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle. J Med Virol, 2020.doi: https://doi.org/10.1002/jmv.25678.
Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA, 2020.doi: https://doi.org/10.1001/jama.2020.0757.
Hui DS, I AE, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 2020;91:264–266.doi: https://doi.org/10.1016/j.ijid.2020.01.009.
Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect, 2020;9(1):221–236.doi: https://doi.org/10.1080/22221751.2020.1719902.
National Health Commission of the People’s Republic China, Novel coronavirus (2019-nCoV): situation. Accessed February 15, 2020. [. http://2019ncov.chinacdc.cn/2019-nCoV/.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020.doi: https://doi.org/10.1016/S0140-6736(20)30183-5.
Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New Engl J Med, 2020.doi: https://doi.org/10.1056/NEJMoa2001017.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020.doi: https://doi.org/10.1016/S0140-6736(20)30211-7.
Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020.doi: https://doi.org/10.1001/jama.2020.1585.
Chen F, Liu ZS, Zhang FR, et al. Frist case of severe childhood novel coronavirus pneumonia in China. Zhonghua Er Ke Za Zhi (Chinese), 2020;58(0):E005. doi: https://doi.org/10.3760/cma.j.issn.0578-1310.2020.0005.
Wei M, Yuan J, Liu Y, et al. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA, 2020.doi: https://doi.org/10.1001/jama.2020.2131.
Pediatric Branch Of Hubei Medical Association PBOW. Recommendation for the diagnosis and treatment of novel coronavirus infection in children in Hubei (Trial version 1). Chin J Contemp Pediatr, 2020;2(22):96–99. doi: https://doi.org/10.7499/j.issn.1008-8830.2020.02.003.
Koh D, Sng J. Lessons from the past: perspectives on severe acute respiratory syndrome. Asia Pac J Public Health, 2010,22(3 Suppl):132S–136S.
Leung CW, Chiu WK. Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children. Paediatr Respir Rev, 2004,5(4):275–288.
Cheng VC, Lau SK, Woo PC, et al. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev, 2007,20(4):660–694.
Alhamlan FS, Majumder MS, Brownstein JS, et al. Case characteristics among Middle East respiratory syndrome coronavirus outbreak and non-outbreak cases in Saudi Arabia from 2012 to 2015. Bmj Open, 2017,7(1):e011865.
Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis, 2008,198(7):962–970.
Fritz CQ, Edwards KM, Self WH, et al. Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children. Pediatrics, 2019,144(1):e20183090.
All authors declare no conflict of interest.
About this article
Cite this article
Zheng, F., Liao, C., Fan, Qh. et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. CURR MED SCI 40, 275–280 (2020). https://doi.org/10.1007/s11596-020-2172-6